HealthQuill Mental health
Anxiety disorders during childhood can impact employment, difficulties in the workplace, and adult depression, a study by the University of Oxford found.
Health Medical Research

Major headway in depression study: 293 new genetic variants found

HQ Team January 20, 2025: Research has unveiled 293 new gene variants linked to major depressive disorder (MDD), significantly enhancing our understanding of.

Read More
Each individual's experiences, genetics, and environment create a unique mental health landscape. What may appear as a debilitating condition for one person could be manageable or even adaptive for another. For instance, introversion might be pathologized in an extroverted society despite being a valid personality trait.
Health Opinion Research

Boundaries between normal and abnormal are often thin and blurred

Each individual's experiences, genetics, and environment create a unique mental health landscape. What may appear as a debilitating condition for one person could.

Read More
Weaving mental science into tortured art geniuses — from Rumi to Van Gogh
Health Medical Opinion Research

Weaving mental science into tortured art geniuses — from Rumi to Van Gogh

Romanticizing agony may seem emotionally fulfilling, but leads to an unhealthy glamorization of struggles and adversities. Although painful memories are part of life.

Read More
Sixty percent of the patients treated with Pfizer’s Lorbrena drug, for a rare form of advanced lung cancer, were alive without disease progression after five years, according to company data.
Health Uncategorized

Review finds links between allergic diseases and mental health conditions

HQ Team November 15, 2024:Allergies are a source of great social and physical impairment for people suffering from them. Treatments are long-drawn, expensive.

Read More
Toxic positivity promotes the belief that individuals should maintain happiness regardless of their circumstances. It discourages negative thoughts, even in situations that naturally evoke sadness, such as losing a loved one or facing job loss.
Health Medical Opinion

Opinion: Take life head-on; forced positivity is fake confidence

Toxic positivity promotes the belief that individuals should maintain happiness regardless of their circumstances. It discourages negative thoughts, even in situations that naturally.

Read More
Imposter syndrome is a psychological phenomenon that affects many high-achieving individuals, often leading them to downplay their accomplishments and attribute their success to luck or external factors.
Drugs Health Medical Opinion

Opinion: Imposter syndrome can lead to anxiety, depression, guilt

By Aparna S October 29, 2024: Imposter syndrome is a psychological phenomenon that affects many high-achieving individuals, often leading them to downplay their.

Read More
Drugs Health Pharma

Ketamine pill may revolutionize treatment for hard-to-treat depression

HQ Team October 25,  2024: A recent study indicates that a new slow-release ketamine pill could offer a promising alternative for individuals suffering.

Read More
Maternal deaths have risen or stagnated globally over recent years, and every two minutes, a woman dies during pregnancy or childbirth, according to the WHO.
Drugs Health Medical

Maternal eating disorder linked to increased psychiatric risks in offspring

Bharti Jayshankar October 24, 2024: In a Finnish population-based cohort study, researchers have found that mothers with a history of eating disorders or.

Read More
Casual use of mental health language often describes behaviours that do not correlate with actual conditions, under the impression that it is “trendy.” 
Health Medical Opinion Pharma

Opinion: Casual mental health words spicing up normal chats not justifiable

By Aparna S October 16, 2024: Is it okay to use mental health words casually in everyday conversations? If you believe that this.

Read More
Mental health
Drugs Health Pharma

FDA approves Cobenfy, a new treatment for schizophrenia

HQ Team 27 September, 2024: The U.S. Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and trospium chloride) for the treatment of schizophrenia in.

Read More